Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-017982
Filing Date
2009-03-16
Accepted
2009-03-16 16:37:13
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-4524_110k.htm 10-K 1675759
2 EX-10.12 a09-4524_1ex10d12.htm EX-10.12 6009
3 EX-23.1 a09-4524_1ex23d1.htm EX-23.1 4034
4 EX-31.1 a09-4524_1ex31d1.htm EX-31.1 13872
5 EX-31.2 a09-4524_1ex31d2.htm EX-31.2 13856
6 EX-32.1 a09-4524_1ex32d1.htm EX-32.1 6001
7 EX-32.2 a09-4524_1ex32d2.htm EX-32.2 6005
9 GRAPHIC g45241bmi001.gif GRAPHIC 6042
10 filename10.htm CORRESP 6875
  Complete submission text file 0001104659-09-017982.txt   1742474
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 09684836
SIC: 2836 Biological Products, (No Diagnostic Substances)